Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. J. Surma"'
Publikováno v:
Nuclear Medicine Communications. 15:628-635
To assess the usefulness of the 99Tcm-N,N'-ethylene-1-dicysteine (99Tcm-EC) complex for examination of kidney function, dynamic kidney scintigraphy with 99Tcm-EC and clearance determinations were performed. During renoscintigraphy the kidney images w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd5fd1c6fb7b4b254ee02e1ed514262b
https://doi.org/10.1097/00006231-199408000-00007
https://doi.org/10.1097/00006231-199408000-00007
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 2(1)
Ethylenedicysteine-99mTc (99mTc-EC) has been more and more commonly applied in dynamic studies as well as for clearance determinations. However, it was necessary to investigate in detail the pharmacokinetic characteristics of the radiopharmaceutical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6a988a737d2040fea7270c56f569a88c
https://pubmed.ncbi.nlm.nih.gov/14600996
https://pubmed.ncbi.nlm.nih.gov/14600996
Autor:
M J, Surma
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 1(1)
The aim of this work has been to assay determination error values for the clearance determined by single- and multi-sample method and to compare the error values obtained for both methods.The assay has been conducted by two independent methods (Monte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7b5217a4d9fad4c270ca14a3b2ed8b4
https://pubmed.ncbi.nlm.nih.gov/14601007
https://pubmed.ncbi.nlm.nih.gov/14601007
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 4(1)
(99m)Tc-HEPIDA total plasma clearance has been used for assessment of hepatic parenchyma damage. However, the radiopharmaceutical used is being partly cleared from plasma also by the urinary tract. As the share of the latter route in total eliminatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ee4a70949ddd2cfcdb9293d4aedc8af
https://pubmed.ncbi.nlm.nih.gov/14600963
https://pubmed.ncbi.nlm.nih.gov/14600963
Autor:
M J, Surma
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 4(2)
The determination of hepatic plasma clearance of( 99m)Tc-HEPI-DA is becoming a clinically attractive test. It is not necessary to perform always the determination using an extensive sampling of blood over the period of 0-90 min post injection of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06eb61a643a54a8ff5296b82500835b7
https://pubmed.ncbi.nlm.nih.gov/14600890
https://pubmed.ncbi.nlm.nih.gov/14600890
Autor:
M J, Surma
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 1(1)
The aim of the present study was an attempt to verify the systemic distribution of 99mTC-ethylenedicysteine by means of the open two-compartment model.In order to accomplish this, 99mTc-EC clearance was determined in 21 patients as: two-compartmental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84da0abf6448e9a6946a41e7ac37f621
https://pubmed.ncbi.nlm.nih.gov/14601006
https://pubmed.ncbi.nlm.nih.gov/14601006
Publikováno v:
Nuclear medicine communications. 15(8)
To assess the usefulness of the 99Tcm-N,N'-ethylene-1-dicysteine (99Tcm-EC) complex for examination of kidney function, dynamic kidney scintigraphy with 99Tcm-EC and clearance determinations were performed. During renoscintigraphy the kidney images w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00df7b233dc9f0e37a0cbebeb76cce04
https://pubmed.ncbi.nlm.nih.gov/7715889
https://pubmed.ncbi.nlm.nih.gov/7715889
Publikováno v:
Nuclear Medicine Communications. 19:514
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b82eba7fe0a1e8d4fe97aa8184543d
https://doi.org/10.1097/00006231-199805000-00081
https://doi.org/10.1097/00006231-199805000-00081
Publikováno v:
Nuklearmedizin. Nuclear medicine. 20(6)
A concept of a kidney uptake coefficient (UC) of 131I-o-hippurate was developed by analogy from the corresponding kidney clearance of blood plasma in the early period after injection of the hippurate. The UC for each kidney was defined as the count-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb14d36883c489f13b018c12730b1aea
https://pubmed.ncbi.nlm.nih.gov/7329809
https://pubmed.ncbi.nlm.nih.gov/7329809